Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Spyre’s arthritis misses; Ideaya ends eye cancer trial

Plus news about United Therapeutics. Spyre Therapeutics reports additional trial failures: The biotech said its long-acting anti-TL1A drug, codenamed SPY072, did not meet the primary endpoints in the psoriatic arthritis or ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

Clinical Psychologists Seek Greater Investment in Mental Health Services for Victims of Insecurity

Yemi Kosoko in Jos Amid growing concerns over the psychological toll of insecurity, displacement and humanitarian crises across Nigeria, the Nigeria Association of Clinical Psychologists (NACP) has…

  • Conference emphasizes integrating psychological care into humanitarian interventions.
  • Women, children, and vulnerable groups disproportionately affected by trauma in Plateau State.

More from Wednesday 4 November →